How – and why – we are tackling opioid use disorder with a monoclonal antibody

Phesi CEO Gen Li discusses the impacts of the conflict between Russia and Ukraine on clinical trials

CPhI North America begins today. Here’s our guide to day 1 at the show.

Preparing for the EU’s new HTA regulation and Joint Clinical Assessment process

Veeva’s Richard Young looks back on breakthroughs in clinical trial technology and why the industry must continue to make trials more patient centric.

How Astrea Bioseparations is expanding its expertise into the advanced medicines space.

Sending out instrumentation to trade shows or customer locations for demonstration purposes is expensive and not risk free. Enter 3D virtual worlds.

We interview Freya Biosciences' Colleen Acosta about the need for more therapies to address healthcare issues specific to women.

Acknowledging the monumental successes of the measles vaccine developer and “true giant” of science, medicine, and public health

Biopharma tech continues to advance so why is downstream processing such a headache?